Increased Anxiety-Like Behavior and Enhanced Synaptic Efficacy in the Amygdala of GluR5 Knockout Mice
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
GABAergic transmission in the amygdala modulates the expression of anxiety. Understanding the interplay between GABAergic transmission and excitatory circuits in the amygdala is, therefore, critical for understanding the neurobiological basis of anxiety. Here, we used a multi-disciplinary approach to demonstrate that GluR5-containing kainate receptors regulate local inhibitory circuits, modulate the excitatory transmission from the basolateral amygdala to the central amygdala, and control behavioral anxiety. Genetic deletion of GluR5 or local injection of a GluR5 antagonist into the basolateral amygdala increases anxiety-like behavior. Activation of GluR5 selectively depolarized inhibitory neurons, thereby increasing GABA release and contributing to tonic GABA current in the basolateral amygdala. The enhanced GABAergic transmission leads to reduced excitatory inputs in the central amygdala. Our results suggest that GluR5 is a key regulator of inhibitory circuits in the amygdala and highlight the potential use of GluR5-specific drugs in the treatment of pathological anxiety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of the amygdala in fear and anxiety
Davis, M. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.002033 · Cited by 2,357 · cited 1×
“In both humans and animals, activation of the amygdala elicits anxiety whereas lesion of the amygdala impairs the perception of fear [5].”
BackgroundVariations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 2×
“Both vesicular and non-vesicular releases of GABA contribute to tonic receptor activation [38], we want to know whether GluR5 modulates different sources of GABA for tonic GABA current.”
BackgroundThe economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242 · cited 1×
“The amygdala is a key circuit for processing neuronal inputs from other parts of the brain, initiating output signals to responding nuclei and generating various physiological responses, including behavioral, autonomic, and hormonal responses related to anxiety [3,4].”
BackgroundBenzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Molecular and neuronal substrate for the selective attenuation of anxiety
Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946 · cited 1×
“GABAA receptors, a family of ligand-gated chloride ion channels, mediate the effects of GABA in anxiety-related behaviors [8–10].”
BackgroundMcKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
Neurotransmission in the rat amygdala related to fear and anxiety
Davis, M., Rainnie, D., & Cassell, M. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90106-6 · Cited by 771 · cited 4×
“c-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the adult mammalian brain, including the amygdala [7].”
BackgroundInfluentialDecreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550 · cited 1×
“Deficiencies in GABAA receptors have been implicated in anxiety-like behavior in mice [11].”
BackgroundTsvetkov, E., Carlezon, W. A., Benes, F. M., Kandel, E. R., & Bolshakov, V. Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00645-1 · Cited by 321
GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells
Cossart, R., Esclapez, M., Hirsch, J. C., Bernard, C., & Ben-Ari, Y. (1998) · Nature Neuroscience · doi:10.1038/2185 · Cited by 315 · cited 1×
“Previous studies conducted in the hippocampus and cortex have demonstrated that KA depolarizes GABAergic interneurons via activation of somatodendritic KA receptors [29–32] while work in the rat spinal dorsal horn [33–35] and BLA [25] suggests that the effect of KA and ATPA are mediated by the presynaptic location of…”
Cited by
Smajić, S., Prada-Medina, C. A., Landoulsi, Z., Ghelfi, J., Delcambre, S., Dietrich, C., Jarazo, J., Henck, J., Balachandran, S., Pachchek, S., et al. (2022) · Brain · doi:10.1093/brain/awab446 · Cited by 590
Elia, J., Gai, X., Xie, H. M., Perin, J. C., Geiger, E., Glessner, J. T., D'arcy, M., deBerardinis, R., Frackelton, E., Kim, C., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.57 · Cited by 529
50 years of hurdles and hope in anxiolytic drug discovery
Griebel, G., & Holmes, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4075 · Cited by 414
Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy
Mitra, R., & Sapolsky, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705615105 · Cited by 409
Koga, K., Descalzi, G., Chen, T., Ko, H.-G., Lu, J., Li, S., Son, J., Kim, T., Kwak, C., Huganir, R. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.021 · Cited by 364
Self-citationNeural Mechanisms Underlying Anxiety–Chronic Pain Interactions
Zhuo, M. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.006 · Cited by 341
Self-citationThe age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 316
Self-Regulation of Breathing as a Primary Treatment for Anxiety
Jerath, R., Crawford, M. W., Barnes, V. A., & Harden, K. (2015) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-015-9279-8 · Cited by 293
Lee, V., & Maguire, J. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00003 · Cited by 228
Neurons in the Amygdala with Response-Selectivity for Anxiety in Two Ethologically Based Tests
Wang, D. V., Wang, F., Liu, J., Zhang, L., Wang, Z., & Lin, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018739 · Cited by 78
“Additionally, anxiety is likely to elicit synaptic plasticity in BLA [35], [36], thus increasing the strength of synaptic transmission and excitability of BLA anxiety-related neurons.”
BackgroundMasneuf, S., Lowery-Gionta, E., Colacicco, G., Pleil, K. E., Li, C., Crowley, N., Flynn, S., Holmes, A., & Kash, T. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.04.015 · Cited by 69
“These prior findings are of particular interest given GluN1 and GluK1 are important regulators of amygdala synaptic transmission and plasticity (Aroniadou-Anderjaska et al., 2012; Lack et al., 2008; Li and Rogawski, 1998; Wu et al., 2007), and more generally, in the context of a growing literature implicating amygdala…”
BackgroundResultInfluential
Metadata
- Authors
- Wu, L.-J., Ko, S. W., Toyoda, H., Zhao, M.-G., Xu, H., Vadakkan, K. I., Ren, M., Knifed, E., Shum, F., Quan, J., Zhang, X.-H., & Zhuo, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-01-24
- Volume
- 2
- Issue
- 1
- Pages
- e167
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2011201599
- Cited by
- 82
- References
- 14
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.